Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Commission gives clearance to Pfizer/Hospira merger

Media release

Issued 16 July 2015
Release no. 5

Commission gives clearance to Pfizer/Hospira merger

The Commerce Commission has given clearance for Pfizer Inc. to acquire all of the shares of Hospira Inc. Both parties are active in the development and supply of a range of pharmaceutical products.

The Commission assessed whether Pfizer and Hospira were close competitors in the limited instances where both compete to supply the same type of small molecule medicines. The Commission also considered whether or not Pfizer or Hospira had medicines in development that would compete against each other without the merger.

Commerce Commission Chair Dr Mark Berry said that the Commission is satisfied the merger will not have, or would not be likely to have, the effect of substantially lessening competition in the affected markets.

“Our investigation found that Pfizer and Hospira were not particularly close competitors for the supply of the overlapping small molecule drugs, and that sufficient competition would remain in the market with the merger,” Dr Berry said.

“We also found that while both Pfizer and Hospira have new biosimilar drugs in development, there are a number of other pharmaceutical companies developing the same drugs which are likely to compete vigorously with the merged entity.”

A public version of the written reasons for the decision will be available shortly on the Clearance Register.


The merger forms part of a global merger that is currently being considered by several other competition authorities.

Pfizer is a global pharmaceutical company with a focus on the research and development of new pharmaceutical products. In New Zealand, Pfizer sells a range of consumer and prescription pharmaceuticals and operates through its subsidiaries Pfizer New Zealand Limited and Pfizer PFE.

Hospira is a global company which focuses on the production and distribution of injectable pharmaceuticals and medication delivery devices. In New Zealand, Hospira operates through its subsidiary Hospira NZ Limited.

© Scoop Media

Business Headlines | Sci-Tech Headlines


Energy Resources Aotearoa: Doubling Of Coal Use Shows Need For Local Natural Gas

New figures showing a near doubling of coal-fired electricity generation highlight New Zealand’s energy shortage and the need for natural gas as a lower carbon alternative, according to Energy Resources Aotearoa... More>>

E Tu: ‘Sense Of Mourning’ As Norske Skog Mill Set To Close

Workers at Norske Skog’s Tasman Mill now know they’ll be losing their jobs in little over a month’s time.
On Wednesday afternoon, workers were told the mill will be stopping production from the end of June... More>>

Stats NZ: Card Spending Sees Strong Growth In May

Seasonally adjusted card spending rose by $189 million (2.3 percent) between April 2021 and May 2021, Stats NZ said today.
Spending rose across all industries for the first time since New Zealand moved to level 1 in June 2020... More>>

Catalist: NZ’s New SME Stock Exchange, Gets Licence To Go Public

New Zealand has a new stock exchange – designed specifically for small and medium-sized businesses (SMEs) to raise up to $20 million a year from the public.
Called Catalist, the exchange has already been successfully working the private investment sector.... More>>

E-Commerce: Over 40% Of Those Engaged In The Bitcoin Community Are Millennials

Bitcoin has emerged to be a popular topic among millennials with digital currency increasingly being viewed as a potential source of creating wealth through investments. The interest in bitcoin by millennials signals the role this age group plays in the possible realization of the digital currency’s mass adoption... More>>

Stats NZ: New Zealand Is Getting Drier

While there is natural variation in precipitation due to seasons and cycles, New Zealand appears to be getting drier, Stats NZ said today... More>>